Nomura Takashi, Kabashima Kenji
Department of Dermatology, Faculty of Medicine, Kyoto University, Kyoto, Japan.
Department of Dermatology, Faculty of Medicine, Kyoto University, Kyoto, Japan.
J Allergy Clin Immunol. 2021 Dec;148(6):1451-1462. doi: 10.1016/j.jaci.2021.10.022. Epub 2021 Oct 29.
Key research advances in atopic dermatitis (AD) suggest the complexity of its endotypes. A comprehensive serum biomarker panel revealed at least 4 types of AD. Some represent classic T2-dominant AD with filaggrin mutations commonly reported in Europeans, a simultaneously activated multipolar axis of cytokines often reported in Asian individuals, and an intrinsic type characterized by T2 inferiority. Innate lymphoid cells, including natural killer cells, natural killer T cells, and fibroblasts, play a role in AD development and heterogeneity. Here, we discuss the endotypes of AD from the perspective of antigen types (hapten vs protein antigens), barrier function, and a novel set of immune cells. Endotypic stratification of AD may lead to the development of customized therapeutic strategies in the future.
特应性皮炎(AD)的关键研究进展表明其内在类型具有复杂性。一个综合的血清生物标志物组揭示了至少4种AD类型。一些代表经典的T2主导型AD,其具有在欧洲人中常见的丝聚蛋白突变;一种在亚洲个体中常报道的同时激活的多极细胞因子轴;以及一种以T2劣势为特征的内在类型。固有淋巴细胞,包括自然杀伤细胞、自然杀伤T细胞和成纤维细胞,在AD的发展和异质性中发挥作用。在此,我们从抗原类型(半抗原与蛋白质抗原)、屏障功能和一组新的免疫细胞的角度讨论AD的内在类型。AD的内型分层可能会在未来导致定制化治疗策略的发展。